Skip to main content

ALK5 Inhibitor II

ALX-270-445

50 citations

  • ALX-270-445-M001   —   1 mg
    $96.00
  • ALX-270-445-M005   —   5 mg
    $382.00
  • Potent ATP-competitive inhibitor of the TGF-β type I receptor ALK5
  • Useful for cellular reprogramming and the culture of human pluripotent stem cells
  • Active in vitro and in vivo
  • GMP format available

ALK5 inhibitor II is a cell permeable, potent, selective and ATP-competitive inhibitor of TGF-β RI kinase (IC50=23nM, 4nM and 18nM for binding, auto-phosphorylation, and cellular assay in HepG2 cells of TGF-β RI kinase, respectively). It minimally affects a panel of nine closely related kinases including p38 MAPKand GSK3 (IC50>16µM). It can be used for the induction of the pluripotency of stem cells by replacing the transcription factor SOX2 via the inhibition of TGF-β signaling and inducing the expression of the transcription factor Nanog.

Shipping: Available products typically ship within 24/48h, via priority shipping.

Do you need support? Contact Customer Service or Technical Support.

Online Account
Access or Create Your Account


Regulatory Status

RUO – Research Use Only


Resources